Facebook Linkedin RSS Twitter Youtube
Home 2024

Phase III clinical trials (Drug development)

MinervaX and Wacker Collaborate on Manufacturing Prophylactic Group B Streptococcus Vaccine
Bioprocessing

MinervaX and Wacker Collaborate on Manufacturing Prophylactic Group B Streptococcus Vaccine

StockWatch: MacroGenics Shares Crater after Trial Deaths
Drug Discovery

StockWatch: MacroGenics Shares Crater after Trial Deaths

FDA Approves Pfizer’s One-Time Gene Therapy BEQVEZ for Hemophilia B
Drug Discovery

FDA Approves Pfizer’s One-Time Gene Therapy BEQVEZ for Hemophilia B

StockWatch: Biogen Q1 Results Beat Expectations, for a Change
Drug Discovery

StockWatch: Biogen Q1 Results Beat Expectations, for a Change

REGENXBIO and AbbVie Advance Wet AMD Gene Therapy to Phase III
Drug Discovery

REGENXBIO and AbbVie Advance Wet AMD Gene Therapy to Phase III

Psychedelics Coming into the Modern Age of Medicine
Insights

Psychedelics Coming into the Modern Age of Medicine

Abivax Advances Ulcerative Colitis Candidate with U.S. IPO
Drug Discovery

Abivax Advances Ulcerative Colitis Candidate with U.S. IPO

StockWatch: Illumina Stays Mum as Short Seller Targets Icahn
GEN Edge

StockWatch: Illumina Stays Mum as Short Seller Targets Icahn

Multiple Vaccine Technologies Converge on Respiratory Syncytial Virus
Insights

Multiple Vaccine Technologies Converge on Respiratory Syncytial Virus

StockWatch: J&J Falls and Rises on Q1 Results, Leaked Data, Trial Halt
Cancer

StockWatch: J&J Falls and Rises on Q1 Results, Leaked Data, Trial Halt

123...110Page 1 of 110
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.